• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience.

作者信息

Rakowski Tomasz, Dziewierz Artur, Siudak Zbigniew, Kleczyński Paweł, Dubiel Jacek S, Dudek Dariusz

机构信息

Second Department of Cardiology, Jagiellonian University Medical College, Kopernika 17 Street, 31-501, Krakow, Poland,

出版信息

J Thromb Thrombolysis. 2014 Apr;37(3):243-5. doi: 10.1007/s11239-013-0930-z.

DOI:10.1007/s11239-013-0930-z
PMID:23624705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3971439/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/3971439/b14822298315/11239_2013_930_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/3971439/b14822298315/11239_2013_930_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/3971439/b14822298315/11239_2013_930_Fig1_HTML.jpg

相似文献

1
Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience.心肌梗死医院网络中新型口服抗血小板药物的引入：初步经验
J Thromb Thrombolysis. 2014 Apr;37(3):243-5. doi: 10.1007/s11239-013-0930-z.
2
Effect of Bruton's tyrosine kinase inhibitors on platelet aggregation in patients with acute myocardial infarction.布鲁顿酪氨酸激酶抑制剂对急性心肌梗死患者血小板聚集的影响。
Thromb Res. 2019 Jul;179:64-68. doi: 10.1016/j.thromres.2019.04.024. Epub 2019 Apr 24.
3
[Platelet inhibitors or anticoagulants in prevention after myocardial infarct? The 1991 state of the art].[心肌梗死后预防中使用血小板抑制剂还是抗凝剂？1991年的最新情况]
Z Gesamte Inn Med. 1992 Jan;47(1):1-5.
4
Oral antithrombotic use among myocardial infarction patients.心肌梗死患者口服抗血栓药物的使用情况。
Ann Pharmacother. 2003 Jan;37(1):143-6. doi: 10.1345/aph.1C038.
5
[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland - authors' reply].[波兰ST段抬高型心肌梗死患者最佳口服抗血小板治疗新模型——作者回复]
Kardiol Pol. 2012;70(3):317-20.
6
The use of antiplatelet medication in hospitalised elderly patients.住院老年患者抗血小板药物的使用
Bratisl Lek Listy. 2015;116(9):533-8. doi: 10.4149/bll_2015_102.
7
Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction.心肌梗死后患者中氯吡格雷抗血小板作用决定因素的时间相关变化。
Eur J Pharmacol. 2014 Nov 5;742:47-54. doi: 10.1016/j.ejphar.2014.08.009. Epub 2014 Sep 6.
8
Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?不稳定型心绞痛/非ST段抬高型心肌梗死、ST段抬高型心肌梗死及经皮冠状动脉介入治疗中的口服抗血小板治疗：是时候更新指南了吗？
Am J Cardiol. 2009 Sep 7;104(5 Suppl):4C-8C. doi: 10.1016/j.amjcard.2009.06.019.
9
[Platelet aggregation and antiplatelet agents in acute coronary syndromes].[急性冠状动脉综合征中的血小板聚集与抗血小板药物]
Med Sci (Paris). 2004 Mar;20(3):291-7. doi: 10.1051/medsci/2004203291.
10
Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Henry Ford Hosp Med J. 1991;39(3-4):195-9.

引用本文的文献

1
Contemporary use of P2Y inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.当代波兰 ST 段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时对 P2Y 抑制剂的应用：来自 ORPKI 全国注册研究的数据。
J Thromb Thrombolysis. 2018 Jan;45(1):151-157. doi: 10.1007/s11239-017-1579-9.
2
Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives.阿昔单抗在ST段抬高型急性心肌梗死治疗中的应用：循证治疗、当前临床应用及未来展望
Ther Clin Risk Manag. 2014 Jul 18;10:567-76. doi: 10.2147/TCRM.S50002. eCollection 2014.

本文引用的文献

1
Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study.氯吡格雷预处理 ST 段抬高型心肌梗死患者对随后普拉格雷负荷后血小板反应性无影响：一项观察性研究中的血小板反应性。
Platelets. 2013;24(7):549-53. doi: 10.3109/09537104.2012.736045. Epub 2012 Dec 5.
2
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.ST段抬高型急性心肌梗死患者管理的欧洲心脏病学会指南
Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24.
3
[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland. Polish Cardiac Society statement].
Kardiol Pol. 2011;69(9):986-94.
4
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.易化经皮冠状动脉介入治疗在高危 ST 段抬高型心肌梗死患者转至非经皮冠状动脉介入治疗医院中的获益。
JACC Cardiovasc Interv. 2009 Oct;2(10):917-24. doi: 10.1016/j.jcin.2009.06.018.
5
Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.在因ST段抬高型心肌梗死行直接经皮冠状动脉介入治疗而转运前早期使用阿昔单抗可降低高危患者的1年死亡率。EUROTRANSFER注册研究结果
Am Heart J. 2009 Oct;158(4):569-75. doi: 10.1016/j.ahj.2009.08.008.
6
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.替格瑞洛与氯吡格雷用于急性冠脉综合征患者的比较
N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.
7
Prasugrel versus clopidogrel in patients with acute coronary syndromes.普拉格雷与氯吡格雷用于急性冠状动脉综合征患者的比较。
N Engl J Med. 2007 Nov 15;357(20):2001-15. doi: 10.1056/NEJMoa0706482. Epub 2007 Nov 4.
8
Inter-individual variability in response to clopidogrel in patients with coronary artery disease.冠状动脉疾病患者对氯吡格雷反应的个体间变异性。
Kardiol Pol. 2005 Feb;62(2):108-17; discussion 118.